General Pharmacology Practice Questions

Q: All of the following drugs cause hemolysis in patients with G-6-PD deficiency except?

Atropine. Glucose-6-Phosphate Dehydrogenase (G-6-PD) deficiency is an X-linked recessive disorder [1] where erythrocytes lack the ability to regenerate reduced **glutathione**. This makes them highly susceptible to oxidative stress, leading to hemoglobin denaturation (Heinz bodies) and hemolysis when exposed to certain oxidizing agents. **Why Atropine is the correct answer:** **Atropine** is a muscarinic antagonist (anticholinergic). It does not possess oxidizing properties and does not interfere with the redox machinery of the red blood cell. Therefore, it is safe to use in G-6-PD deficient patients. **Analysis of incorrect options:** * **Primaquine:** This is the classic "high-risk" drug for G-6-PD deficiency. It is an 8-aminoquinoline that generates reactive oxygen species (ROS), causing severe oxidative hemolysis [1]. * **Chloroquine & Quinine:** Both are antimalarials that can induce hemolysis in G-6-PD deficient individuals, though the risk is significantly lower compared to Primaquine. They are generally considered "intermediate risk" but are contraindicated or require close monitoring in severe deficiency. **High-Yield Clinical Pearls for NEET-PG:** * **Common Triggers:** Mnemonic **"AAA"** – **A**ntimalarials (Primaquine), **A**ntibiotics (Sulfonamides, Nitrofurantoin, Dapsone), and **A**spirin (in high doses). Fava beans (Favism) are a classic dietary trigger. * **Diagnosis:** Peripheral smear shows **Heinz bodies** (denatured hemoglobin) and **Bite cells** (result of splenic macrophages removing Heinz bodies). * **Key Contraindication:** Never give Primaquine without screening for G-6-PD levels, as it can precipitate a life-threatening hemolytic crisis.

Q: Sodium and/or potassium ions are involved in the mechanism of action of which of the following receptors?

All of the above. **Explanation:** The correct answer is **All of the above** because all three receptors listed are linked to ion channels (either directly or indirectly) that regulate the flux of sodium ($Na^+$) and/or potassium ($K^+$) ions. 1. **Neuromuscular ($N_m$) and Neuronal ($N_n$) Receptors:** These are **Ionotropic receptors** (Ligand-gated ion channels). When Acetylcholine binds to these nicotinic receptors, it causes the opening of a central pore that is permeable to both $Na^+$ and $K^+$. The rapid influx of $Na^+$ leads to depolarization, which triggers an action potential (muscle contraction in $N_m$ and post-ganglionic firing in $N_n$). 2. **Dopamine Receptors:** These are **Metabotropic receptors** (G-Protein Coupled Receptors - GPCRs). While they don't form a channel themselves, their downstream signaling significantly affects ion conductance. For example, $D_2$ receptors are coupled to $G_i/G_o$ proteins, which often lead to the **opening of $K^+$ channels** (causing hyperpolarization) and the **inhibition of $Na^+$ or $Ca^{2+}$ channels**. **Why "All of the above" is correct:** While the mechanism differs (direct gating for Nicotinic vs. indirect modulation for Dopamine), all three receptors fundamentally rely on the movement of $Na^+$ and/or $K^+$ to exert their physiological effects. **High-Yield Clinical Pearls for NEET-PG:** * **Nicotinic Receptors ($N_m, N_n$):** Always excitatory; work via rapid $Na^+$ influx. * **G-Protein Modulation:** $G_i$ coupled receptors (like $D_2, M_2, \alpha_2$) typically increase $K^+$ efflux, leading to membrane stabilization/hyperpolarization. * **Fast vs. Slow:** Ionotropic receptors (Nicotinic) act in milliseconds, whereas Metabotropic (Dopamine) act in seconds to minutes.

Q: The fall in blood pressure caused by d-tubocurarine is due to which of the following mechanisms?

All of the above. **Explanation:** **d-Tubocurarine (d-TC)** is a prototype non-depolarizing neuromuscular blocker that causes a significant fall in blood pressure through a multi-factorial mechanism: 1. **Histamine Release:** d-TC is a potent inducer of mast cell degranulation. The released histamine causes systemic vasodilation and increased capillary permeability, leading to a drop in peripheral vascular resistance and blood pressure. 2. **Ganglionic Blockade:** At therapeutic doses, d-TC can block nicotinic receptors ($N_n$) at the autonomic ganglia. This reduces sympathetic outflow to the blood vessels, further contributing to hypotension. 3. **Reduced Venous Return:** The drug causes profound skeletal muscle relaxation. The loss of the "skeletal muscle pump" action, combined with the vasodilation mentioned above, leads to peripheral pooling of blood and a subsequent decrease in venous return to the heart. **Why "All of the above" is correct:** Since d-TC simultaneously triggers histamine release, inhibits autonomic ganglia, and reduces the muscle pump effect, all three mechanisms synergistically contribute to the observed hypotension. **Clinical Pearls for NEET-PG:** * **Mnemonic:** d-Tubocurarine "**T**errible" for BP (Histamine + Ganglia). * **Modern Alternatives:** Newer agents like **Vecuronium** and **Rocuronium** are preferred in clinical practice because they lack histamine-releasing and ganglion-blocking properties, making them cardiovascularly stable. * **Atracurium:** Also causes histamine release but is unique for its metabolism via **Hofmann elimination** (spontaneous degradation), making it safe in liver and kidney failure. * **Antidote:** Hypotension caused by d-TC is managed with fluids and vasopressors, while the neuromuscular block is reversed using **Neostigmine** (plus Glycopyrrolate).

Q: Prostaglandins are used in all except?

Palliative treatment of Patent Ductus Arteriosus (PDA). The correct answer is **D. Palliative treatment of Patent Ductus Arteriosus (PDA)**. ### **Explanation of the Correct Answer** The goal in managing a **Patent Ductus Arteriosus (PDA)** is usually to **close** it, not maintain it. Prostaglandins (specifically PGE1) are used to **keep the ductus arteriosus open** in neonates with ductal-dependent congenital heart defects (e.g., Transposition of the Great Arteries) [1, 2]. To treat/close a PDA, **NSAIDs** (Prostaglandin synthesis inhibitors) like **Indomethacin** or **Ibuprofen** are used. Therefore, prostaglandins are not used for the treatment of PDA itself. ### **Analysis of Incorrect Options** * **A. Cervical Ripening:** **PGE2 (Dinoprostone)** and **PGE1 (Misoprostol)** are gold-standard agents used to soften the cervix and induce labor by increasing proteoglycan synthesis and collagenase activity [1, 2, 3, 4]. * **B. Postpartum Hemorrhage (PPH):** **PGF2α (Carboprost)** and **PGE1 (Misoprostol)** are potent uterotonics used to control bleeding by causing strong uterine contractions when oxytocin is insufficient [2, 4]. * **C. Erectile Dysfunction:** **PGE1 (Alprostadil)** can be injected intracavernosally or applied intraurethrally. It acts as a vasodilator by increasing cAMP, facilitating an erection [2]. ### **High-Yield NEET-PG Pearls** * **Alprostadil (PGE1):** Used for maintaining ductal patency (pre-surgery) and Erectile Dysfunction [1, 2]. * **Misoprostol (PGE1):** Used for NSAID-induced peptic ulcers, medical abortion (with Mifepristone), and PPH [2, 3, 4]. * **Latanoprost (PGF2α):** First-line for Open-Angle Glaucoma (increases uveoscleral outflow) [2, 3]. * **Epoprostenol (PGI2):** Used in Pulmonary Arterial Hypertension [2]. * **Closure of PDA:** Remember the mnemonic "Come In" (**C**lose with **I**ndomethacin); **Keep Open** with **PGE1** [1, 2].

Q: Which of the following are prodrugs?

All of these. **Explanation:** A **prodrug** is a pharmacologically inactive compound that must undergo chemical or enzymatic biotransformation within the body to be converted into its active metabolite. This strategy is often used to improve bioavailability, reduce toxicity, or enhance site-specificity. * **Mercaptopurine (Option A):** This is a purine analogue used in leukemia. It is inactive in its parent form and must be converted by the enzyme **HGPRT** into **6-thioinosinic acid** (the active nucleotide) to inhibit DNA synthesis. * **Dipivefrine (Option B):** It is a prodrug of **Epinephrine** used in glaucoma. Being more lipophilic than epinephrine, it penetrates the cornea much more effectively. Once inside the eye, it is hydrolyzed by esterases into active epinephrine. * **Enalapril (Option C):** Most ACE inhibitors (except Captopril and Lisinopril) are prodrugs. Enalapril is converted by hepatic esterases into **Enalaprilat**, which is the potent inhibitor of the Angiotensin-Converting Enzyme. Since all three medications require metabolic activation, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Prodrugs:** "**A**ll **P**rodrugs **C**an **E**nter **D**e **L**iver **M**aking **S**ome **P**otent **H**ormones" (**A**CEIs (except Capto/Lisino), **P**roton Pump Inhibitors, **C**yclophosphamide, **E**nalapril, **D**opa (L-Dopa), **L**evodopa, **M**ercaptopurine, **S**ulindac, **P**rednisone, **H**eroin). * **Exceptions:** **Captopril and Lisinopril** are the only ACE inhibitors that are **NOT** prodrugs. * **Advantage:** Prodrugs like **Levodopa** can cross the blood-brain barrier, whereas the active form (Dopamine) cannot.

Q: The enzyme pseudocholinesterase acts on which of the following drugs?

Suxamethonium. **Explanation:** **Correct Answer: D. Suxamethonium** **Mechanism:** Suxamethonium (Succinylcholine) is a depolarizing neuromuscular blocker. Its short duration of action (5–10 minutes) is due to its rapid hydrolysis by **Pseudocholinesterase** (also known as Butyrylcholinesterase or Plasma Cholinesterase), which is synthesized in the liver and found in the plasma. Unlike Acetylcholine, Suxamethonium is not metabolized by Acetylcholinesterase at the motor endplate. **Analysis of Incorrect Options:** * **A. Decamethonium:** Although it is a depolarizing blocker like Suxamethonium, it is not metabolized by cholinesterases; it is excreted unchanged in the urine. * **B. Tubocurarine:** This is a long-acting non-depolarizing blocker. It is primarily excreted in the urine (70%) and bile, and is not metabolized by pseudocholinesterase. * **C. Gallamine:** This is another non-depolarizing blocker that is excreted entirely unchanged by the kidneys. **NEET-PG High-Yield Pearls:** 1. **Suxamethonium Apnea:** Patients with a genetic deficiency or atypical variant of pseudocholinesterase (detected by a low **Dibucaine Number**) cannot metabolize the drug, leading to prolonged paralysis and respiratory failure. 2. **Site of Synthesis:** Pseudocholinesterase is produced in the **liver**. Its levels may decrease in chronic liver disease, leading to prolonged Suxamethonium action. 3. **Drugs metabolized by Pseudocholinesterase:** Remember the mnemonic **"P-M-C-S"**: **P**rocaine, **M**ivacurium, **C**ocaine, and **S**uxamethonium. 4. **Antidote:** There is no specific pharmacological reversal for Suxamethonium; management of apnea is via mechanical ventilation and fresh frozen plasma (which contains the enzyme).

Q: Which of the following is NOT known as an immunosuppressive agent?

Cephalosporin. **Explanation:** The correct answer is **B. Cephalosporin**. **Why Cephalosporin is the correct answer:** Cephalosporins are a class of **β-lactam antibiotics** derived from the fungus *Acremonium*. They function by inhibiting bacterial cell wall synthesis (binding to penicillin-binding proteins). They possess **antimicrobial** properties, not immunosuppressive ones. While they treat infections, they do not suppress the host's immune response. **Analysis of Incorrect Options:** * **A. Prednisolone:** A potent **Glucocorticoid** that suppresses the immune system by inhibiting NF-κB, decreasing the production of pro-inflammatory cytokines (IL-1, IL-6), and inducing apoptosis of T-lymphocytes. * **C. Azathioprine:** A **Purine Antimetabolite** (prodrug of 6-mercaptopurine). It inhibits DNA synthesis, thereby preventing the proliferation of rapidly dividing cells, particularly T and B lymphocytes. * **D. Cyclosporin:** A **Calcineurin Inhibitor**. It binds to cyclophilin to inhibit calcineurin, preventing the dephosphorylation of NFAT (Nuclear Factor of Activated T-cells). This specifically inhibits the transcription of **Interleukin-2 (IL-2)**, a key driver of T-cell proliferation. **High-Yield Clinical Pearls for NEET-PG:** * **Confusion Alert:** Do not confuse **Cyclosporin** (Immunosuppressant) with **Cephalosporin** (Antibiotic) due to their similar phonetic endings. * **Cyclosporin Side Effects:** Remember the "6 H's"—Hypertrichosis (hirsutism), Hyperplasia of gums, Hypertension, Hyperlipidemia, Hyperkalemia, and Hepatotoxicity/Nephrotoxicity. * **Drug of Choice:** Azathioprine is frequently used in steroid-sparing regimens for autoimmune diseases like SLE and Rheumatoid Arthritis.

Question 1

All of the following drugs cause hemolysis in patients with G-6-PD deficiency except?

Accepted Answer

Atropine

Answer

Primaquine

Answer

Chloroquine

Answer

Quinine

Question 2

Sodium and/or potassium ions are involved in the mechanism of action of which of the following receptors?

Accepted Answer

All of the above

Answer

Dopamine receptor

Answer

Neuromuscular (Nm) receptor

Answer

Neuronal (Nn) receptor

Question 3

The fall in blood pressure caused by d-tubocurarine is due to which of the following mechanisms?

Accepted Answer

All of the above

Answer

Reduced venous return

Answer

Ganglionic blockade

Answer

Histamine release

Question 4

What is the characteristic shape of a dose-response curve demonstrating hormesis?

Accepted Answer

Inverted U or J shaped

Answer

Straight line

Answer

Sigmoid

Answer

Hyperbola

Question 5

Tolerance and physical dependence may occur after chronic use of all of the following agents EXCEPT?

Accepted Answer

Clomipramine

Answer

Meperidine

Answer

Phenobarbital

Answer

Diazepam

Question 6

Prostaglandins are used in all except?

Accepted Answer

Palliative treatment of Patent Ductus Arteriosus (PDA)

Answer

Cervical ripening

Answer

Postpartum hemorrhage (PPH)

Answer

Erectile dysfunction

Question 7

Which of the following are prodrugs?

Accepted Answer

All of these

Answer

Mercaptopurine

Answer

Dipivefrine

Answer

Enalapril

Question 8

What is meant by drug efficacy?

Accepted Answer

The maximal intensity of response that can be produced by a drug.

Answer

The effectiveness of a drug in life-threatening conditions.

Answer

The dose of the drug needed to produce half of the maximal effect.

Answer

The minimum dose of the drug needed to produce a toxic effect.

Question 9

The enzyme pseudocholinesterase acts on which of the following drugs?

Accepted Answer

Suxamethonium

Answer

Decamethonium

Answer

Tubocurarine

Answer

Gallamine

Question 10

Which of the following is NOT known as an immunosuppressive agent?

Accepted Answer

Cephalosporin

Answer

Prednisolone

Answer

Azathioprine

Answer

Cyclosporin

General Pharmacology — MCQs

General Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?